$ISRG
Intuitive Surgical, Inc. · NasdaqGS · Healthcare
- Market cap
- 131.38B
- Volume
- 2.08M
- P/E
- 42.00
- Day range
- 363.31 – 369.55
- 52w range
- 328.57 – 603.88
- Analyst target
- 478.01
AI Summary
Generating a unique summary for ISRG…
AI-generated for information only — not investment advice.
Share this ticker
$ISRG -0.85% at 366.70 Warren Buffett and 3 other tracked billionaires hold it. $JNJ $NTRA $LLY https://billionairestrading.com/stocks/ISRG
Company summary
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Institutional ownership
Institutions hold 89.58% · insiders 0.51% · 3,145 institutions
| Holder | Shares | Value | % held | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 30.02M | $11.01B | 8.50% | 2026-06-30 |
| Vanguard Capital Management LLC | 23.13M | $8.48B | 6.55% | 2026-06-30 |
| State Street Corporation | 16.06M | $5.89B | 4.55% | 2026-06-30 |
| Invesco Ltd. | 11.84M | $4.34B | 3.35% | 2026-06-30 |
| Price (T.Rowe) Associates Inc | 11.26M | $4.13B | 3.19% | 2026-06-30 |
| Geode Capital Management, LLC | 8.53M | $3.13B | 2.42% | 2026-06-30 |
| Capital World Investors | 7.74M | $2.84B | 2.19% | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.24M | $2.66B | 2.05% | 2026-06-30 |
| Morgan Stanley | 6.56M | $2.41B | 1.86% | 2026-06-30 |
| NORGES BANK | 4.95M | $1.82B | 1.40% | 2026-06-30 |
Hedge fund & billionaire activity
Insider transactions
| Insider | Role | Transaction | Shares | Date |
|---|---|---|---|---|
| BROSIUS MARK PRESTON | Officer | Sale at price 375.57 - 396.37 per share. | 154.00 | 2026-08-21 |
| BROSIUS MARK PRESTON | Officer | Sale at price 390.67 - 394.26 per share. | 231.00 | 2026-08-19 |
| LADD AMY L | Director | Sale at price 379.00 - 393.10 per share. | 472.00 | 2026-08-11 |
| GUTHART GARY S | Director | Sale at price 400.00 per share. | 10.0K | 2026-08-11 |
| LOEB GARY | Officer | Sale at price 379.00 per share. | 400.00 | 2026-08-10 |
| BROSIUS MARK PRESTON | Officer | Sale at price 346.83 - 351.00 per share. | 56.00 | 2026-07-31 |
| BROSIUS MARK PRESTON | Officer | Sale at price 344.00 - 365.58 per share. | 84.00 | 2026-07-29 |
| ROSA DAVID J | Chief Executive Officer | — | 1.9K | 2026-07-10 |
| BROSIUS MARK PRESTON | Officer | Sale at price 412.16 - 414.13 per share. | 48.00 | 2026-06-12 |
| BROSIUS MARK PRESTON | Officer | Sale at price 420.12 - 424.14 per share. | 69.00 | 2026-06-10 |
| LOEB GARY | Officer | Sale at price 424.14 per share. | 400.00 | 2026-06-10 |
| ROSA DAVID J | Chief Executive Officer | — | 1.4K | 2026-06-10 |
Analyst ratings
Consensus score 1.82 (1 = strong buy, 5 = sell) · mean target 478.01
- OppenheimerOutperformup2026-08-12
- HSBCHolddown2026-07-30
- Raymond JamesOutperformmain2026-07-17
- Piper SandlerOverweightreit2026-07-17
- JP MorganOverweightmain2026-07-17
- MizuhoNeutralmain2026-07-17
- Wells FargoOverweightmain2026-07-17
- TD CowenBuymain2026-07-17
- Evercore ISI GroupIn-Linemain2026-07-17
- RBC CapitalOutperformmain2026-07-17
Earnings
Next report: 2026-10-20
| Quarter | EPS actual | EPS estimate | Surprise |
|---|---|---|---|
| 3Q2025 | 2.40 | 1.99 | 0.41 |
| 4Q2025 | 2.53 | 2.27 | 0.26 |
| 1Q2026 | 2.50 | 2.11 | 0.39 |
| 2Q2026 | 2.80 | 2.50 | 0.30 |
SEC filings
- 8-KCorporate Changes & Voting Matters2026-07-27Open
- S-8Offering Registrations2026-07-21Open
- 8-KCorporate Changes & Voting Matters2026-07-16Open
- 8-KCorporate Changes & Voting Matters2026-05-28Open
- SDSpecialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)2026-05-21Open
- 8-KCorporate Changes & Voting Matters2026-05-04Open
- 10-QPeriodic Financial Reports2026-04-22Open
- 8-KCorporate Changes & Voting Matters2026-04-21Open
- ARSAnnual Report to Shareholders2026-03-13Open
- 8-KCorporate Changes & Voting Matters2026-03-02Open
Latest ISRG news
- ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine
Intuitive Surgical's Ion platform is gaining momentum, with rising procedures, a larger installed base and global expansion fueling a second growth engine.
Mon, 07 Sep 2026 14:51:00 +0000
- Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth
Sands Capital, an investment management company, released its second-quarter 2026 investor letter for “Sands Capital Global Growth Fund”. The letter can be downloaded here. Global Growth seeks the best growth businesses worldwide, leveraging a research team that explores both developed and emerging markets for sustainable competitive advantages. In the quarter, global equities rebounded strongly, driven […]
Mon, 07 Sep 2026 12:30:44 +0000
- Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning?
Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold.
Sat, 05 Sep 2026 19:35:00 +0000
- Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separates a compounder from a cyclical recovery story.
Fri, 04 Sep 2026 14:45:42 +0000
- ISRG Stock: The Best House On The Block Costs The Most
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium.
Wed, 02 Sep 2026 19:37:49 +0000
- Global Surgical Robots Market to Reach $10.6 Billion in 2026, Driven by AI Integration and Minimally Invasive Surgery
Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and FreehandDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Surgical Robots Market by Offering of Surgical Robot Developers, Deployment Model, Type of Surgical Procedure Supported, Application Area, End Users and Key Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.
Mon, 07 Sep 2026 08:21:00 +0000
- 2 Stocks Down 8% or More That Are Screaming Buys Right Now
You might regret ignoring these companies at current levels.
Fri, 04 Sep 2026 14:50:00 +0000
- Are Robots the New Normal? Bet on these ETFs to Invest in the Future
Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
Fri, 04 Sep 2026 11:49:00 +0000